106
Participants
Start Date
June 30, 2020
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2026
Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy
Toripalimab: 240 mg, Q3W, starting on D1, for totally 12 cycles Endostar: 7.5 mg/m2/d, continuous intravenous pumping for 10 days, Q3W, starting on D1, for totally 5 cycles
IC＋CCRT
IC＋CCRT
Collaborators (1)
Shandong Cancer Hospital and Institute
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
The Affiliated Hospital Of Guizhou Medical University
OTHER
Xiangya Hospital of Central South University
OTHER
Jiangxi Provincial Cancer Hospital
OTHER
Zhejiang Cancer Hospital
OTHER
Fourth Affiliated Hospital of Guangxi Medical University
OTHER
LiuZhou People's Hospital
OTHER
Guilin Medical College
OTHER
Affiliated Hospital of North Sichuan Medical College
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER